Previous Close | 35.39 |
Open | 35.24 |
Bid | 35.17 x 0 |
Ask | 35.19 x 0 |
Day's Range | 34.91 - 35.31 |
52 Week Range | 27.99 - 41.50 |
Volume | |
Avg. Volume | 2,238,088 |
Market Cap | 32.776B |
Beta (5Y Monthly) | 0.79 |
PE Ratio (TTM) | 11.09 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 1.96 (5.61%) |
Ex-Dividend Date | Dec 01, 2022 |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for GWO.TO
Great-West Lifeco will release its fourth quarter 2022 financial results after markets close on Wednesday, February 8, 2023.
Great-West Lifeco Inc. (the "Corporation") announced today that it has received approval from the Toronto Stock Exchange ("TSX") for the renewal of its Normal Course Issuer Bid ("NCIB").
Great-West Lifeco Inc. ("Lifeco") has been notified of an unsolicited mini-tender offer by Obatan LLC, made to residents of Ireland, to purchase up to 50,000 common shares of Lifeco. The unsolicited offer represents a discount of approximately 31.1% to the closing price of the common shares on the TSX on December 29, 2022, the last trading day before the offer was commenced. The common shares do not trade on a recognized stock exchange in Ireland.